18-46433322-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_152470.3(ARK2C):āc.194G>Cā(p.Ser65Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,612,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_152470.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARK2C | NM_152470.3 | c.194G>C | p.Ser65Thr | missense_variant | 2/8 | ENST00000269439.12 | NP_689683.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNF165 | ENST00000269439.12 | c.194G>C | p.Ser65Thr | missense_variant | 2/8 | 2 | NM_152470.3 | ENSP00000269439.6 | ||
RNF165 | ENST00000593230.5 | c.-8G>C | 5_prime_UTR_variant | 2/5 | 3 | ENSP00000467730.1 | ||||
RNF165 | ENST00000543885.2 | c.-91-14241G>C | intron_variant | 2 | ENSP00000444285.1 | |||||
RNF165 | ENST00000586604.5 | n.62-14241G>C | intron_variant | 2 | ENSP00000468365.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000414 AC: 1AN: 241838Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 131792
GnomAD4 exome AF: 0.00000617 AC: 9AN: 1459834Hom.: 0 Cov.: 32 AF XY: 0.00000689 AC XY: 5AN XY: 726198
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152312Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 03, 2024 | The c.194G>C (p.S65T) alteration is located in exon 2 (coding exon 2) of the RNF165 gene. This alteration results from a G to C substitution at nucleotide position 194, causing the serine (S) at amino acid position 65 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at